Hannah joined Drug Discovery News as an assistant editor in 2022. She earned her PhD in neuroscience from the University of Washington in 2017 and completed the Dalla Lana Fellowship in Global Journalism in 2020. Her work has appeared in The New York Times, Undark, and New Scientist. She enjoys playing soccer and hiking and hopes to be a contestant on The Great Canadian Baking Show one day.
For decades, treatment options for sickle cell disease have been extremely limited. Soon, gene therapies and a host of pharmaceuticals could alleviate the immense burden of this disease.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.